| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Cytos Biotechnology, AG,
Department of Dermatology and
Institute of Experimental Immunology, University Hospital, and
Elektronenmikroskopisches Zentrallabor Universität, Zurich, Switzerland
Virus-like particles (VLPs) are known to induce strong Ab responses in the absence of adjuvants. In addition, VLPs are able to prime CTL responses in vivo. To study the efficiency of this latter process, we fused peptide p33 derived from lymphocytic choriomeningitis virus to the hepatitis B core Ag, which spontaneously assembles into VLPs (p33-VLPs). These p33-VLPs were efficiently processed in vitro and in vivo for MHC class I presentation. Nevertheless, p33-VLPs induced weak CTL responses that failed to mediate effective protection from viral challenge. However, if APCs were activated concomitantly in vivo using either anti-CD40 Abs or CpG oligonucleotides, the CTL responses induced were fully protective against infection with lymphocytic choriomeningitis virus or recombinant vaccinia virus. Moreover, these CTL responses were comparable to responses generally induced by live vaccines, because they could be measured in primary ex vivo 51Cr release assays. Thus, while VLPs alone are inefficient at inducing CTL responses, they become very powerful vaccines if applied together with substances that activate APCs.
This article has been cited by other articles:
|
|
 |
|
  H. Jusforgues-Saklani, M. Uhl, N. Blachere, F. Lemaitre, O. Lantz, P. Bousso, D. Braun, J. J. Moon, and M. L. Albert Antigen Persistence Is Required for Dendritic Cell Licensing and CD8+ T Cell Cross-Priming J. Immunol., September 1, 2008; 181(5): 3067 - 3076. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Barth, E. K. Schnober, C. Neumann-Haefelin, C. Thumann, M. B. Zeisel, H. M. Diepolder, Z. Hu, T. J. Liang, H. E. Blum, R. Thimme, et al. Scavenger Receptor Class B Is Required for Hepatitis C Virus Uptake and Cross-Presentation by Human Dendritic Cells J. Virol., April 1, 2008; 82(7): 3466 - 3479. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Lacasse, J. Denis, R. Lapointe, D. Leclerc, and A. Lamarre Novel Plant Virus-Based Vaccine Induces Protective Cytotoxic T-Lymphocyte-Mediated Antiviral Immunity through Dendritic Cell Maturation J. Virol., January 15, 2008; 82(2): 785 - 794. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Unsoeld, K. Mueller, U. Schleicher, C. Bogdan, J. Zwirner, D. Voehringer, and H. Pircher Abrogation of CCL21 chemokine function by transgenic over-expression impairs T cell immunity to local infections Int. Immunol., November 1, 2007; 19(11): 1281 - 1289. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Bartholdy, S. O. Kauffmann, J. P. Christensen, and A. R. Thomsen Agonistic Anti-CD40 Antibody Profoundly Suppresses the Immune Response to Infection with Lymphocytic Choriomeningitis Virus J. Immunol., February 1, 2007; 178(3): 1662 - 1670. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. S. Liu, J. Dyer, G. R. Leggatt, G. J. P. Fernando, J. Zhong, R. Thomas, and I. H. Frazer Overcoming Original Antigenic Sin to Generate New CD8 T Cell IFN-{gamma} Responses in an Antigen-Experienced Host. J. Immunol., September 1, 2006; 177(5): 2873 - 2879. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Spohn, K. Schwarz, P. Maurer, H. Illges, N. Rajasekaran, Y. Choi, G. T. Jennings, and M. F. Bachmann Protection against Osteoporosis by Active Immunization with TRANCE/RANKL Displayed on Virus-Like Particles J. Immunol., November 1, 2005; 175(9): 6211 - 6218. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. Marsland, C. Nembrini, N. Schmitz, B. Abel, S. Krautwald, M. F. Bachmann, and M. Kopf Innate signals compensate for the absence of PKC-{theta} during in vivo CD8+ T cell effector and memory responses PNAS, October 4, 2005; 102(40): 14374 - 14379. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Onate, G. Donoso, G. Moraga-Cid, H. Folch, S. Cespedes, and E. Andrews An RNA Vaccine Based on Recombinant Semliki Forest Virus Particles Expressing the Cu,Zn Superoxide Dismutase Protein of Brucella abortus Induces Protective Immunity in BALB/c Mice Infect. Immun., June 1, 2005; 73(6): 3294 - 3300. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Barth, A. Ulsenheimer, G. R. Pape, H. M. Diepolder, M. Hoffmann, C. Neumann-Haefelin, R. Thimme, P. Henneke, R. Klein, G. Paranhos-Baccala, et al. Uptake and presentation of hepatitis C virus-like particles by human dendritic cells Blood, May 1, 2005; 105(9): 3605 - 3614. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Boisgerault, P. Rueda, C. M. Sun, S. Hervas-Stubbs, M. Rojas, and C. Leclerc Cross-Priming of T Cell Responses by Synthetic Microspheres Carrying a CD8+ T Cell Epitope Requires an Adjuvant Signal J. Immunol., March 15, 2005; 174(6): 3432 - 3439. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. B. J. Wong and R. F. Siliciano Contribution of Virus-Like Particles to the Immunogenicity of Human Immunodeficiency Virus Type 1 Gag-Derived Vaccines in Mice J. Virol., February 1, 2005; 79(3): 1701 - 1712. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Ruedl, K. Schwarz, A. Jegerlehner, T. Storni, V. Manolova, and M. F. Bachmann Virus-Like Particles as Carriers for T-Cell Epitopes: Limited Inhibition of T-Cell Priming by Carrier-Specific Antibodies J. Virol., January 15, 2005; 79(2): 717 - 724. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. Bachmann, K. Schwarz, P. Wolint, E. Meijerink, S. Martin, V. Manolova, and A. Oxenius Cutting Edge: Distinct Roles for T Help and CD40/CD40 Ligand in Regulating Differentiation of Proliferation-Competent Memory CD8+ T Cells J. Immunol., August 15, 2004; 173(4): 2217 - 2221. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Storni and M. F. Bachmann Loading of MHC Class I and II Presentation Pathways by Exogenous Antigens: A Quantitative In Vivo Comparison J. Immunol., May 15, 2004; 172(10): 6129 - 6135. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Storni, C. Ruedl, K. Schwarz, R. A. Schwendener, W. A. Renner, and M. F. Bachmann Nonmethylated CG Motifs Packaged into Virus-Like Particles Induce Protective Cytotoxic T Cell Responses in the Absence of Systemic Side Effects J. Immunol., February 1, 2004; 172(3): 1777 - 1785. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Freigang, D. Egger, K. Bienz, H. Hengartner, and R. M. Zinkernagel Endogenous neosynthesis vs. cross-presentation of viral antigens for cytotoxic T cell priming PNAS, November 11, 2003; 100(23): 13477 - 13482. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Storni, C. Ruedl, W. A. Renner, and M. F. Bachmann Innate Immunity Together with Duration of Antigen Persistence Regulate Effector T Cell Induction J. Immunol., July 15, 2003; 171(2): 795 - 801. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Lazdina, M. Alheim, J. Nystrom, C. Hultgren, G. Borisova, I. Sominskaya, P. Pumpens, D. L. Peterson, D. R. Milich, and M. Sallberg Priming of cytotoxic T cell responses to exogenous hepatitis B virus core antigen is B cell dependent J. Gen. Virol., January 1, 2003; 84(1): 139 - 146. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
